Navigation Links
UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
Date:7/4/2012

AMSTERDAM, July 5, 2012 /PRNewswire/ -- Leading events organiser UBM Conferences, a division of UBM Plc (LSE: UBM), has announced details for its Generics and Biosimilars Conference to be held in Istanbul from September 18th to 20th at the Hilton Garden Inn Istanbul Golden Horn. The conference will focus on the advantages and challenges of operating in the evolving generics and biosimilars markets including: market potential; how to address pricing; legislative and regulatory hurdles; and the emergence of the EMEA regions including Central and Eastern Europe, the Commonwealth of Independent States (CIS), Turkey and the Middle East.

The three-day programme includes a full agenda of presentations, discussions and workshops that can be found here. Confirmed speakers for the Conference include high profile domestic and global representatives from companies like Merck, Sharpe and Dohme, Teva, Merck Bioventures, Pfizer, Biocad, Novartis, Mylan, Glenmark Generics and more, as well as support from the Bulgarian Generics Pharmaceutical Association, Jordanian Association of Pharmaceutical Manufacturers, the Russian Pharma Licensing Group and the Generics Bulletin.

"This year's event aims to facilitate networking and discussion between global and domestic players who are active in key pharmerging markets," stated Conference Producer, Joel Hornby.  "The Economist Intelligence Unit (EIU) forecasts five MENA markets will represent a combined GDP of US $2.5 trillion by 2016, led by Turkey and Saudi Arabia and the IHS Global Insight forecasts continued growth of about 10% in Russia. Now is the time to cultivate business relationships within this market, and the Generics and Biosimilars Conference offers an exceptional platform to do so."

Comprised of executives from business development, product development, sales and marketing, regulatory, scientific research and affairs, and R&D from across the globe, the event will begin with an optional pre-conference session on the present and future potential for the Russian and CIS markets. It will move forward in daily single-track programmes that are broken out into sessions ranging from half hour to a full hour, including built-in networking opportunities. These sessions offer attendees the opportunity to hear the very latest developments in generics, supergenerics and biosimilar innovations, as well as gaining insight into current business activity and where the real opportunities for these emerging markets exist. The final day of the programme will feature a special focus Masterclass where attendees can learn how to locate and maximise opportunities in the Middle East.

To view the full Generics and Biosimilars Conference agenda with topics, times, and speaker information please click here.  Registration is now open and Early Bird tickets will be available until July 13.

Notes for Editors:

UBM Conferences is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmconferences.com.


'/>"/>
SOURCE UBM Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. NYSE Companies and NASDAQ Companies June 7th Investor Presentations Now Available at RetailInvestorConferences.com
2. PDL BioPharma to Present at Upcoming Conferences
3. Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
4. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
5. Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March
6. Organovo, Inc. Investor Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
8. Organovo, Inc. to Webcast, Live, at RetailInvestorConferences.com on March 1st
9. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
10. Orexigen Therapeutics to Present at Upcoming Conferences
11. Ambit Biosciences to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
Breaking Biology News(10 mins):